Rheumatol Int. 2012 Dec;3212:4005-13. doi: 10.1007/s00296-011-2333-9. Epub 2012 Jan 3.

Value of diffusion-weighted magnetic resonance imaging in early diagnosis of ankylosing spondylitis.

Ai F1Ai TLi XHu DZhang WMorelli JN.

Author information

Abstract

The objective of this study is to estimate the value of diffusion-weighted MRI DWI in the detection of abnormalities in sacroiliac joints in the patients with early ankylosing spondylitis AS and investigate the feasibility of whole-body DWI WB-DWI in systemic evaluation of AS. Sixteen patients with early AS, 18 patients with simple low back pain LBP, and 18 healthy volunteers were involved in this study. All subjects underwent conventional MRI and DWI. Apparent diffusion coefficient ADC in subchondral bone marrows of sacroiliac joints was measured. Independent-sample t test was used to statistically analyze the difference of ADC values between groups. WB-DWI was performed in additional 12 patients with clinically confirmed AS. The image results were analyzed by multiple post-processing techniques, as compared to conventional MRI. In AS patients, mean ADC values were 0.494 ± 0.170 × 10-3 mm2/s in sacrum and 0.513 ± 0.129 × 10-3 mm2/s in ilium, which were significantly higher than those of LBP ((0.306 ± 0.057 × 10-3 mm2/s in sacrum and 0.323 ± 0.083 × 10-3 mm2/s in ilium and healthy volunteers ((0.315 ± 0.009 × 10-3 mm2/s in sacrum and 0.319 ± 0.012 × 10-3 mm2/s in ilium. No statistical differences were found between simple LBP and healthy volunteers. Mean ADC value of multiple lesions in AS was 0.932 ± 0.299 × 10-3 mm2/s. By WB-DWI, abnormal signals of sacroiliac joints and extra-sacroiliac joint lesions were demonstrated in the locations corresponding with clinical findings. Mean ADC values of multiple lesions were 1.298 ± 0.323 × 10-3 mm2/s in sacrum and 1.216 ± 0.311 × 10-3 mm2/s in ilium. DWI and WB-DWI were shown to be effective in differentiation and systemic evaluation of early AS. Both techniques are likely to play an importance role in the early diagnosis of AS and assessment of treatment response.

PMID: 22212412 DOI: 10.1007/s00296-011-2333-9 [PubMed - indexed for MEDLINE]


| 回复

登录后进行回复

发新帖
  • 回复
  • 点评
  • 评分
  • 分享

推荐帖子